Flora Growth Corp. (FLGC) - Dilution Analysis

S-3 filing: This prospectus relates to 966,497 common shares of Flora Growth Corp. that may be sold from time to time by the Selling Securityholders.

8-K filing: Flora Growth Corp. entered into a note settlement agreement with DeFi Development Corp. to settle a Solana-denominated convertible note by paying Solana, cash, and common shares.

S-1 filing: This S-1 filing outlines a proposed offering involving the sale of common shares by a selling shareholder and the potential issuance of shares under an ELOC agreement.

10-Q filing | 0.7M shares outstanding

8-K filing: Flora Growth Corp. entered into multiple private placement agreements, including cash, token, and note offerings, and an equity transfer agreement, to raise capital and restructure its business. ($228.96M proceeds)

8-K filing: Stock split 1-for-39 | Outstanding: 22,568,653 → 578,683

10-Q filing | 22.6M shares outstanding

S-3 filing: Flora Growth Corp. is offering 3,860,003 common shares through a shelf registration for selling securityholders. The company will not receive any proceeds from the sale.

10-Q filing | 22.6M shares outstanding

8-K filing: Flora Growth Corp. issued 3,133,011 common shares and 726,992 pre-funded warrants in a private placement, with net proceeds of approximately US$1,100,000.

S-3/A filing: This S-3/A filing relates to 3,211,508 common shares of Flora Growth Corp. offered by selling securityholders. The company will not receive any proceeds from the sale.

10-K filing | 19.4M shares outstanding

S-3 filing: This S-3 filing relates to 3,211,508 common shares of Flora Growth Corp. being offered by selling securityholders.

8-K filing: Flora Growth Corp. purchased 100% of United Beverage Distribution Inc. and issued 923,744 shares of its common stock to the sellers (excluding Flora insiders) and promissory notes in the aggregate principal amount of $2,845,700.

8-K filing: Flora Growth Corp. completed a registered direct offering of 2,850,000 common shares at an unstated price, resulting in net proceeds of approximately $3.1 million for general corporate purposes. ($3.1M proceeds)

8-K filing: Flora Growth Corp. completed an offering of 425,000 common shares at $1.67 per share, resulting in gross proceeds of approximately $709,750. ($0.71M proceeds)

10-Q filing | 13.4M shares outstanding

10-Q filing | 13.4M shares outstanding

8-K filing: Flora Growth Corp. acquired Australian Vaporizers Pty Ltd. by issuing 550,000 common shares to Lifeist Wellness Inc., valued at $0.7 million. ($0.7M proceeds)

10-Q filing | 12.8M shares outstanding

S-3 filing: This prospectus relates to 2,135,199 common shares of Flora Growth Corp. issued to the selling securityholders pursuant to a Stock Purchase Agreement by and between the Company and TruHC Holding GmbH that may be sold from time to time by the Selling Securityholders.

8-K filing: Flora Growth Corp. will acquire TruHC Pharma GmbH in exchange for 2,770,562 common shares, with 2,135,199 shares issued at the first closing and 635,363 shares to be issued upon shareholder approval. ($6.4M proceeds)

8-K filing: Flora Growth Corp. completed an offering of 1,700,000 common shares at a price of $1.90 per share, resulting in net proceeds of approximately $2.8 million. ($2.8M proceeds)

8-K filing: Flora Growth Corp. entered into a binding letter of intent to acquire all of the issued and outstanding shares of TruHC Pharma GmbH, issuing 2,770,562 common shares to the seller in two steps, with the first step involving the issuance of shares representing 19.99% of Flora's outstanding common shares at $2.31 per share. ($6.4M proceeds)

10-K filing | 9.0M shares outstanding

10-Q filing | 8.2M shares outstanding

S-1 filing: This S-1 filing pertains to the offering of 1,423,760 common shares by selling securityholders, underlying outstanding warrants. The company will not receive any proceeds from the sale of these shares.

8-K filing: Flora Growth Corp. completed a registered direct offering and private placement, selling 1,369,000 common shares and warrants to purchase up to 1,369,000 common shares, with net proceeds of approximately $2.4 million, and amended existing warrants to adjust the exercise price to $2.50 per share and extend the termination date.

8-K filing: Flora Growth Corp. will acquire all the issued and outstanding common shares of Australian Vaporizers Pty Ltd. in exchange for the issuance to Lifeist Wellness Inc. of an aggregate maximum of 600,676 common shares in the capital of Flora, valued at $1.7 million. ($1.7M proceeds)

S-3/A filing: Flora Growth Corp. files an S-3/A form to register the offering of common shares, warrants, and units, with an aggregate offering price not exceeding $80,000,000.

S-3 filing: Flora Growth Corp. files an S-3 registration statement to offer common shares, warrants, and units up to an aggregate initial offering price of $10,000,000.

10-Q filing | 6.9M shares outstanding

8-K filing: Stock split 1-for-20 | Outstanding: 135,573 → 6,778

10-Q filing | 0.1M shares outstanding

10-K filing | 0.1M shares outstanding

F-3 filing: Flora Growth Corp. intends to offer common shares, warrants and units for sale, with an aggregate offering price not to exceed $25,000,000.

20-F filing | 65.5M shares outstanding

F-1 filing: This F-1 filing details a follow-on public offering by Flora Growth Corp., involving units comprised of common shares and warrants, with the intent to fund operating capacity, working capital, and general corporate purposes.

F-1 filing: This is an F-1 filing for Flora Growth Corp. about offering of common stock and underwriter warrants.